Phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous administration of Fovisa (Anti-PDGF-B pegylated aptamer) administered in combination with an anti VEGF agent compared to anti-VEGF monotherapy in subjects with subfoveal neovascular age related macular degeneration (AMD)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: since 01/07/2014
Description
Keywords: Klinische Studie; Fovista
Funding identifier: OPHTH1003
Funder / funding scheme:
- Parexel International GmbH
- Ophthotech Corporation
Project management at the University of Münster
| Eter, Nicole | Clinic for Ophthalmology |
Applicants from the University of Münster
| Eter, Nicole | Clinic for Ophthalmology |